Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
02/2002
02/07/2002WO2001030333A3 Tissue factor antagonists and methods of use thereof
02/07/2002US20020016468 Pesticidal 1-arylpyrazole derivatives
02/07/2002US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/07/2002US20020016351 New crystals of celecoxib
02/07/2002US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
02/07/2002US20020016333 Pyrazoles and pyrazolopyrimidines having crf antagonistic activity
02/07/2002US20020016326 Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors
02/07/2002DE10122097A1 Pyrazolylbiphenylcarboxamide Pyrazolylbiphenylcarboxamide
02/07/2002CA2417650A1 Indazole derivatives as jnk inhibitors and compositions and methods related thereto
02/07/2002CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002CA2415078A1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
02/06/2002EP1177188A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders
02/06/2002EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands
02/06/2002EP1177185A1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents
02/06/2002EP0843551B1 Endothelin receptor antagonists
02/06/2002EP0772598B1 Preparation of heterocyclic- and carbocyclic-substituted benzoic acids
02/06/2002CN1334807A 1-heterocycle substd. diarylamines
02/06/2002CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/05/2002US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis
02/05/2002US6344474 Use of central cannabinoid receptor antagonists for regulating appetence
01/2002
01/31/2002WO2002008834A1 Radiation sensitive compositions containing image quality and profile enhancement additives
01/31/2002WO2002008197A1 Biphenyl carboxamides
01/31/2002WO2002008196A1 5-(m-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES
01/31/2002WO2002008195A1 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms
01/31/2002WO2001081347A3 Diazabicyclic central nervous system active agents
01/31/2002WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens
01/31/2002US20020013357 Valdecoxib compositions
01/31/2002US20020012977 Enzymatic oxidations
01/31/2002US20020012182 Squarylium dye and filter for display device
01/31/2002DE10035011A1 Pure N,N'-carbonyl-diazole preparation in high yield, by reacting azolide salt with phosgene in aromatic or ether solvent
01/31/2002DE10034803A1 Substituierte Sulfonsäureanilide Substituted Sulfonsäureanilide
01/30/2002EP1176142A1 Process for the preparation of pyrazoles
01/30/2002EP1176140A1 Amide compounds and medicinal use thereof
01/30/2002EP1175383A1 Glucocorticoid receptor modulators
01/30/2002EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
01/30/2002CN1333769A Thiourea inhibitors of herps viruses
01/30/2002CN1333767A Aromatic heterocyclic compounds as antiinflammatory agent
01/29/2002US6342608 Reacting organometallic reagent with activated carboxylic acid to form ketone, treating with mixture of carbon disulfide and dihalomethane to form dithietane, reacting with hydrazine derivative to form thiol-substituted pyrazole, alkylating
01/29/2002US6342516 Phenylazole compounds, process for producing the same and drugs for hyperlipemia
01/29/2002US6342510 Antiinflammatory agents and enzyme inhibitors
01/29/2002US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/24/2002WO2002006512A2 Method for detecting uracil biosynthesis inhibitors and their use as herbicides
01/24/2002WO2002006276A1 Beta3 adrenergic agonists
01/24/2002WO2002006244A1 Heterocyclic substituted herbicidal sulphonic acid anilides
01/24/2002WO2002005848A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
01/24/2002WO2002005815A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
01/24/2002WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
01/24/2002WO2001053268B1 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation
01/24/2002WO2001032627A8 Process of making substituted pyrazoles
01/24/2002WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method
01/24/2002US20020010338 Phenyl-keto-imidazolidine thioamide derivatives
01/24/2002US20020010204 Use as pesticides.
01/24/2002US20020009650 High electroconductivity
01/24/2002CA2416039A1 Method for detecting uracil biosynthesis inhibitors and their use as herbicides
01/24/2002CA2415331A1 Beta3 adrenergic agonists
01/24/2002CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
01/24/2002CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
01/23/2002EP1173414A1 N-protected amines and their use as prodrugs
01/23/2002EP1173169A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
01/23/2002EP0888291B1 New process for preparing pesticidal intermediates
01/23/2002CN1332739A 3-(heterocyclyl)-benzoylpyrazole-derivatives
01/23/2002CN1332738A 3-(heterocyclyl)-substituted benzoylpyrazols
01/23/2002CN1332730A Process for preparing insecticide
01/23/2002CN1078202C Method of preparing essentially pure isomers of alpha-bis-oximes
01/22/2002CA2015714C Stable aqueous formulations of fluorescent whitening agents
01/17/2002WO2002004424A1 Pyrazole derivatives
01/17/2002US20020006952 Kinase inhibitors; anticancer agents
01/17/2002US20020006951 Solid-state form of celecoxib having enhanced bioavailability
01/17/2002US20020006947 Aryl substituted pyrazoles, triazoles, and tetrazoles, and the use thereof
01/17/2002US20020006922 Metalloprotease inhibitors
01/17/2002DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments
01/17/2002DE10033097A1 Verfahren zur Herstellung von hochreaktiven(semi)kristallinen und amorphen blockierten Polyisocyanaten A process for preparing highly reactive (semi) crystalline and amorphous blocked polyisocyanates
01/17/2002DE10032132A1 Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung A dermal therapeutic system containing NSAIDs with selective COX-2 inhibition
01/17/2002CA2415492A1 Pyrazole derivatives
01/16/2002CN1331563A Fungicide mixture
01/16/2002CN1331076A Condensed pyrazole compound, composition containing it and its application
01/16/2002CN1331075A Process for synthesizing raw difenzoquat powder by dehydrogenating sulfur
01/15/2002US6339099 Guanidine mimics as factor Xa inhibitors
01/15/2002US6339046 Pyrazde herbicides
01/15/2002US6339042 Herbicidal N-cyclohexadienyl heteroaryloxyacetamides
01/15/2002US6338741 Composition for dyeing keratin fibers which contain at least one diaminopyrazole, dyeing process, novel diaminopyrazoles and process for their preparation
01/10/2002WO2002002512A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002111A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
01/10/2002WO2001056993A3 Pyrazole compositions useful as inhibitors of erk
01/10/2002US20020004522 Nervous system disorders
01/10/2002US20020004518 Pyrazolyl compound; anticoagulants, antiproliferative agent
01/10/2002CA2410651A1 Compounds to treat alzheimer's disease
01/09/2002EP1170316A1 Process for producing highly reactive (semi)crystalline and amorphous blocked polyisocyanates
01/09/2002EP1169038A1 Cyclic protein tyrosine kinase inhibitors
01/09/2002EP1168920A1 (s)-enantiomer enriched fipronil composition
01/09/2002CN1330639A Method for producing 1-substituted 5-or 3-hydroxypyrazoles
01/09/2002CN1330072A Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound
01/08/2002CA2150703C Substituted pyrazoles
01/08/2002CA2080140C Photodynamic plant defoliants and chlorophyll biosynthesis modulators
01/07/2002CA2352675A1 Process for preparing highly reactive (semi) crystalline and amorphous blocked polyisocyanates
01/03/2002WO2002000665A1 Use of potassium channel openers for the treatment of insulitis
01/03/2002WO2002000651A2 Factor xa inhibitors
01/03/2002WO2002000627A1 A crystalline form of celecoxib
01/03/2002US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity
01/03/2002US20020002195 Pesticidal 1-polyarylpyrazoles